ArticleFrontiers in oncology2025

Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma.

Lu-Huai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.